121 related articles for article (PubMed ID: 1634901)
1. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport.
Barbiroli B; Funicello R; Iotti S; Montagna P; Ferlini A; Zaniol P
J Neurol Sci; 1992 Jun; 109(2):188-95. PubMed ID: 1634901
[TBL] [Abstract][Full Text] [Related]
2. Muscle energy metabolism in female DMD/BMD carriers: a 31P-MR spectroscopy study.
Barbiroli B; Funicello R; Ferlini A; Montagna P; Zaniol P
Muscle Nerve; 1992 Mar; 15(3):344-8. PubMed ID: 1557082
[TBL] [Abstract][Full Text] [Related]
3. Further impairment of muscle phosphate kinetics by lengthening exercise in DMD/BMD carriers. An in vivo 31P-NMR spectroscopy study.
Barbiroli B; McCully KK; Iotti S; Lodi R; Zaniol P; Chance B
J Neurol Sci; 1993 Oct; 119(1):65-73. PubMed ID: 8246012
[TBL] [Abstract][Full Text] [Related]
4. Cellular energetics of dystrophic muscle.
Kemp GJ; Taylor DJ; Dunn JF; Frostick SP; Radda GK
J Neurol Sci; 1993 Jun; 116(2):201-6. PubMed ID: 8393092
[TBL] [Abstract][Full Text] [Related]
5. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study.
Lodi R; Kemp GJ; Muntoni F; Thompson CH; Rae C; Taylor J; Styles P; Taylor DJ
Brain; 1999 Jan; 122 ( Pt 1)():121-30. PubMed ID: 10050900
[TBL] [Abstract][Full Text] [Related]
6. A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.
Vainzof M; Passos-Bueno MR; Pavanello RC; Schreiber R; Zatz M
J Med Genet; 1992 Jul; 29(7):476-9. PubMed ID: 1640426
[TBL] [Abstract][Full Text] [Related]
7. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages.
Vainzof M; Pavanello RC; Pavanello I; Tsanaclis AM; Levy JA; Passos-Bueno MR; Rapaport D; Zatz M
Neuromuscul Disord; 1991; 1(3):177-83. PubMed ID: 1822792
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
Mizuno Y; Nonaka I; Hirai S; Ozawa E
J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
[TBL] [Abstract][Full Text] [Related]
9. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
10. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.
Hoogerwaard EM; Bakker E; Ippel PF; Oosterwijk JC; Majoor-Krakauer DF; Leschot NJ; Van Essen AJ; Brunner HG; van der Wouw PA; Wilde AA; de Visser M
Lancet; 1999 Jun; 353(9170):2116-9. PubMed ID: 10382696
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins.
Mora M; Morandi L; Piccinelli A; Gussoni E; Gebbia M; Blasevich F; Dworzak F; Cornelio F
J Neurol; 1993 Sep; 240(8):455-61. PubMed ID: 8263549
[TBL] [Abstract][Full Text] [Related]
12. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
13. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
14. In vivo 31P nuclear magnetic resonance spectroscopy of skeletal muscle energetics in endotoxemic rats: a prospective, randomized study.
Gilles RJ; D'Orio V; Ciancabilla F; Carlier PG
Crit Care Med; 1994 Mar; 22(3):499-505. PubMed ID: 8125002
[TBL] [Abstract][Full Text] [Related]
15. Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy.
McCully K; Giger U; Argov Z; Valentine B; Cooper B; Chance B; Bank W
Muscle Nerve; 1991 Nov; 14(11):1091-8. PubMed ID: 1745283
[TBL] [Abstract][Full Text] [Related]
16. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.
Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
J Med Genet; 1993 Sep; 30(9):728-36. PubMed ID: 8411067
[TBL] [Abstract][Full Text] [Related]
17. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
Griffiths RD; Cady EB; Edwards RH; Wilkie DR
Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of dystrophin in carriers of Duchenne muscular dystrophy.
Clerk A; Rodillo E; Heckmatt JZ; Dubowitz V; Strong PN; Sewry CA
J Neurol Sci; 1991 Apr; 102(2):197-205. PubMed ID: 2072119
[TBL] [Abstract][Full Text] [Related]
19. An in vivo study of muscle phosphate metabolism in Becker's dystrophy by 31P NMR spectroscopy.
Newman RJ
Metabolism; 1985 Aug; 34(8):737-40. PubMed ID: 4021805
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
